| Product Candidate | Indication | Development Stage in the United States | Development Stage in Europe | Cadence Commercial Rights |
| OFIRMEV™ | Treatment of acute pain - adults | Phase III | Marketed (by BMS) |
United States, Canada |
| Treatment of acute pain - pediatrics | Phase III | Marketed (by BMS) |
United States, Canada | |
| Treatment of fever - adults | Phase III | Marketed (by BMS) |
United States, Canada | |
| Treatment of fever - pediatrics | Phase III | Marketed (by BMS) |
United States, Canada |